Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Azzam Dandashi"'
Autor:
Nagi S. El-Saghir, Zaher K. Otrock, Rahif Jalloul, Ali Shamseddine, Azzam Dandashi, Nizar Bitar, Hanan R. Yassine, Zeina Abdel-Khalek, M. Khalifeh, Mahmoud H. Wehbeh, Maya Charafeddine, Aref Chehal, Moussa Dheiny
Publikováno v:
Oncology. 70:330-338
Background: We tested a sequential combination regimen using cisplatin and vinorelbine (PVn) followed by docetaxel as first-line chemotherapy in a phase II clinical trial in metastatic breast cancer (MBC). Patients and Methods: Thirty-five patients w
Autor:
Nizar Bitar, Ali Shamseddine, Jaber Abbas, Teddy Saliba, Azzam Dandashi, Rahif Jalloul, Yasser Abou Mourad, Aref Chehal, Ali T. Taher, Fady Geara, Mohammed Khalifeh
Publikováno v:
American journal of clinical oncology. 28(4)
Acuna LR, 1999, J CLIN ONCOL, V17, P74; ANTOINE EC, 1997, P 7 INT C ANT TREAT; BERNARD A, 1998, P AN M AM SOC CLIN, V17, P491; BOTTO HG, 1998, P AN M AM SOC CLIN, V17, P498; BRUNO S, 1995, AM J CLIN ONCOL-CANC, V18, P392, DOI 10.1097-00000421-1995100
Autor:
Ali Shamseddine, Nagi S. El Saghir, Azzam Dandashi, Buthaina Dabaja, Ziad Salem, Ali T. Taher
Publikováno v:
American journal of clinical oncology. 22(3)
The purpose of this study was to evaluate the combination of cisplatin and vinorelbine (PVn) for relapsed and chemotherapy-pretreated metastatic breast cancer. Twenty-three patients with metastatic breast cancer and prior chemotherapy were entered in
Autor:
N. El-Saghir, Azzam Dandashi, A. Shamseddine, Maya Charafeddine, M. Khalifeh, Nizar Bitar, R. Jalloul, H. Yassine, Z. Abdel Khalik, Zaher K. Otrock
Publikováno v:
Journal of Clinical Oncology. 24:10683-10683
10683 Background: Many chemotherapeutic options exist for metastatic breast cancer (MBC) but there is no standard regimen. We tested a sequential combination regimen using Cisplatinum and Vinorelbine (PVn) followed by Docetaxel as first-line chemothe
Autor:
M. Dheiny, Y Abou Mourad, T Abu Nasr, Azzam Dandashi, Aref Chehal, A. Shamseddine, N.S El Saghir, M Wehbet, Nizar Bitar, Rahif Jalloul
Publikováno v:
European Journal of Cancer Supplements. 2:131